Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details